🔎 Trials Near Me

Beranda › Obesitas › Georgia › Roswell

Uji klinis Obesitas di Roswell, GA

12 studi untuk Obesitas mencari peserta di lokasi sekitar Roswell (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Menerima pesertaFase 2
  • North Georgia Clinical Research, Woodstock · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Woodstock · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Menerima pesertaFase 3
  • Research Site, Woodstock · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • East Coast Institute for Research LLC at Canton Georgia, Canton · 17 mi jauhnya
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Canton · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Canton · 17 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Menerima pesertaFase 2
  • North Georgia Clinical Research, Woodstock · 11 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Menerima pesertaFase 3Sukarelawan sehat diterima
  • ACCOMPLISH-2 Research Site, Woodstock · 11 mi jauhnya
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Menerima pesertaFase 3
  • North Georgia Clinical Research, Woodstock · 11 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • American Clinical Trials, LLC, Acworth · 18 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Menerima pesertaFase 3
  • ACCOMPLISH-1 Research Site, Woodstock · 11 mi jauhnya
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361

Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

Menerima pesertaSukarelawan sehat diterima
  • Kennesaw State Universityh, Kennesaw · 15 mi jauhnya
Usia 20 ke atas · Semua jenis kelamin · Diperbarui 27 Okt 2025 · NCT07221279

Uji klinis Obesitas di kota lain

Studi lain di Roswell

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.